In Latin America, Colgate’s innovation in Palmolive and Protex bar soaps helped strengthen its leadership position. The company now has a market share of 29.9% in bar soaps.
Also, the launch of Hill’s Prescription Diet c/d Urinary Stress for curing feline urinary tract disease was supported by a comprehensive in-clinic communication plan and an extensive sampling program to veterinarians and their clients. This new product contributed to 1% volume growth in pet nutrition and improved market share in high growth countries like the US, Canada, and Europe.
A key innovation and productivity enabler has been Colgate’s strong network of relationships with stakeholders, including customers, medical professionals, and scientists. Colgate is also open to new ideas. Inventors are invited to submit product ideas in the fields of personal and oral healthcare.
The Consumer Staples Select Sector ETF (XLP) and the SPDR S&P Dividend ETF (SDY) have 3.5% and 0.9%[1. Updated as on July 10, 2015] of their respective holdings invested in CL.
View more information: https://marketrealist.com/2015/07/colgates-world-care-brand-innovation/